Elan pays $204m epilepsy drug fine
Health / Medicine Related News
Irish drugmaker Elan has agreed to pay a $204m fine over its marketing practices for its anti-epilepsy drug Zonegran, in a settlement reached with US prosecutors
Source: FT.com - Pharmaceuticals